#Oligonucleotide
(CEJ) Synthesis of Oligonucleotide Conjugates Employing a Diselenide Linker: Chemistry – A European Journal, Volume 32, Issue 37, 1 October 2026. (/CEJ)
Synthesis of Oligonucleotide Conjugates Employing a Diselenide Linker
Chemistry – A European Journal, Volume 32, Issue 37, 1 October 2026.
dlvr.it
October 2, 2026 at 10:03 AM
🧬 Charting new horizons in nucleic acid medicine.
OTDC 2027 explores emerging advances in oligonucleotide therapeutics, RNA & mRNA, innovative delivery technologies, and research collaboration—connecting ideas that can move the field forward.
📅 May 11–12, 2027 | 📍 Boston, MA
🔗 oligo-nucleotide.com
October 2, 2026 at 4:07 AM
Phage proteases activate CBASS antiphage immunity | Science
Phage proteases activate CBASS antiphage immunity
Cyclic oligonucleotide–based antiphage signaling systems (CBASS) are bacterial immune pathways evolutionarily related to cGAS-STING (cyclic GMP-AMP synthase–stimulator of interferon genes) in humans. ...
www.science.org
October 2, 2026 at 12:06 AM
#apaperaday The @worldmusclesociety.org #WMS2026 special continues with a pick from Stenler et al in @moltherapy.bsky.social nucleic acids on a comparison of antisense oligonucleotide (ASO) treatment in adult and very old mice. DOI 10.1016/j.omtn.2026.103017
October 1, 2026 at 11:02 PM
Our story with @hobbslabutah.bsky.social discovering CBASS sensing of phage proteases out now in @science.org

New data include CBASS recognition of diverse proteases beyond T4, and verifying CD-NTase activation loop cleavage as the trigger for defense in vivo
www.science.org/doi/10.1126/...
October 1, 2026 at 7:07 PM
🔬EV-D68 exploits the host miR-3156-3p/K+ channel axis to exit cells. Infection upregulates miR-3156-3p downregulating K+ channels and disrupting ionic balance. A miR-3156-3p antisense oligonucleotide halted viral release and eased acute flaccid paralysis in mice www.sciencedirect.com/science/arti...
www.sciencedirect.com
October 1, 2026 at 12:11 PM
🧬 Better molecules. Smarter delivery. Real-world impact.

OTDC 2027 brings together emerging advances in oligonucleotide therapeutics, RNA & mRNA, and innovative delivery technologies shaping the future of medicine.

📅 May 11–12, 2027 | 📍 Boston, MA & Virtual
🔗 oligo-nucleotide.com
#OTDC2027
October 1, 2026 at 3:52 AM
Epigenetics Update - Photolabile oligonucleotides with topological light gradients enable spatially resolved single-cell transcriptomics and epigenomics www.nature.com/articles/s41...

Maxwell Z. Wilson & Siddharth S. Dey in Nat Biotech

#Epigenetics #SingleCell #Multiomics
---

epigenometech.com
Photolabile oligonucleotides with topological light gradients enable spatially resolved single-cell transcriptomics and epigenomics - Nature Biotechnology
A photolabile oligonucleotide system enables spatially resolved single-cell measurements to show how the epigenome regulates gene expression.
www.nature.com
September 30, 2026 at 4:29 PM
(BioRxiv All) Programmable sequence-resolved in situ profiling of glycoRNA-protein interactomes by GlycoRNA-Map: Cell-surface glycoRNAs participate in diverse biological processes, but they were investigated as pooled populations and the protein interactome of individual… #BioRxiv #MassSpecRSS
Programmable sequence-resolved in situ profiling of glycoRNA-protein interactomes by GlycoRNA-Map
Cell-surface glycoRNAs participate in diverse biological processes, but they were investigated as pooled populations and the protein interactome of individual glycoRNA species remain unresolved. Here we develop GlycoRNA-Map, a programmable photocatalytic proximity-labeling method that maps proteins surrounding sequence-defined endogenous glycoRNAs on living cells. A sialic-acid-binding aptamer and an RNA-hybridization probe jointly recruit a fluorophore-modified oligonucleotide through dual recognition of the glycan and RNA moieties of glycoRNAs. Light-activated biotinylation followed by quantitative mass spectrometry identified 200-418 enriched proteins for each of five glycoRNAs in A549 cells. Comparison of these proteomes revealed limited overlap among different glycoRNA sequences and across cell types, demonstrating that glycoRNA-associated protein environments depend on both RNA identity and cellular context. Transforming growth factor-{beta} receptors 1 and 2 (TGFBR1 and TGFBR2) were identified in the proximal proteomes of multiple glycoRNAs. Removal of cell-surface RNAs enhanced TGF-{beta} receptor signaling and promoted cell migration, demonstrating that glycoRNAs can functionally regulate extracellular signaling by interacting with their protein neighborhoods. GlycoRNA-Map thus provides an accessible strategy for resolving sequence-specific glycoRNA-protein interactome and discovering their roles in membrane signaling.
dlvr.it
September 30, 2026 at 1:13 PM
September: #MuscularDystrophy Awareness Month
🔹DMD | PMO exon skipping; PPMOs & AOCs aim to improve muscle delivery
🔹DM1 | ASOs & AOCs target DMPK RNA
🔹OPMD | Gene therapy approaches are under exploration
🔹LGMD | Gene therapy & oligonucleotide approaches are being investigated for selected subtypes
September 30, 2026 at 12:00 PM
🧬 Antibodies meet programmable nucleic acids.
A new #LabMedDiscovery review explores antibody–oligonucleotide conjugates (AOCs)—
🔬 One platform, bridging diagnostics and therapeutics
www.sciencedirect.com/science/arti...

#AOC #LaboratoryMedicine #MultiOmics #RNA #Diagnostics
September 30, 2026 at 6:07 AM
⏰ The deadline is TODAY!

Register for OTDC 2027 and connect with advances in Oligonucleotide Therapeutics, RNA Technologies, Drug Delivery, CRISPR & Aptamer Technologies.

📅 May 11–12, 2027 | Boston + Hybrid
🔗 oligo-nucleotide.com

#OTDC2027 #Oligonucleotides #RNATherapeutics #DrugDelivery
September 30, 2026 at 5:41 AM
From molecular insights to life-changing therapies 🧬

OTDC 2027 brings together emerging advances in Oligonucleotide Therapeutics, RNA Technologies, Drug Delivery, CRISPR & Aptamer Technologies.

📅 May 11–12, 2027
📍 Boston | Hybrid
🔗 oligo-nucleotide.com

#OTDC2027 #Oligonucleotides #RNATherapeutics
September 30, 2026 at 4:45 AM
(A Chem) RNabel─A
Standalone Software Tool for Annotating
Tandem Mass Spectra of Modified Ribonucleic Acids: AbstractRibonucleic
acid (RNA) modifications, with over 170 identified
types, play diverse roles in cellular processes. The past decade has
witnessed a surging demand for… #MassSpecRSS
RNabel─A Standalone Software Tool for Annotating Tandem Mass Spectra of Modified Ribonucleic Acids
AbstractRibonucleic acid (RNA) modifications, with over 170 identified types, play diverse roles in cellular processes. The past decade has witnessed a surging demand for accurate identification and localization of RNA modifications in both endogenous and synthetic therapeutic RNAs. With accurate spectral annotation for RNA, tandem mass spectrometry (MS/MS) can meet this demand. Here, we present RNabel, a user-friendly software tool for in-depth annotation of MS/MS spectra of RNA oligonucleotides. RNabel considers a full set of backbone-cleavage ions (a, b, c, d, a-B, w, x, y, z) in which the ribonucleotide unit could be A, U, C, G, Y (pseudouridine), or I (Inosine). Additionally, RNabel considers 196 modifications on the base, the phosphoribose linkage, the 5′ or the 3′ terminus, or the detachment of a subnucleotide fragment as a neutral or charged group. Users can create new components if needed, including ribonucleotides, modifications, and neutral or charged groups that could detach from a ribonucleotide. RNabel efficiently processes large data sets in four acceptable formats including .mgf, .raw, .txt from msConvert, and RNabel batch files. Multiple statistical metrics are provided for quality assessment of spectral annotation. To accelerate RNA modification analysis, RNabel is made freely available for Mac and Windows users at https://github.com/songge1111/RNabel/releases.
dlvr.it
September 29, 2026 at 9:02 AM
🧬 From sequence to solution.
OTDC 2027 explores emerging advances in oligonucleotide therapeutics, RNA medicines, and innovative delivery technologies shaping the future of healthcare.

📅 May 11–12, 2027 | Boston, MA & Virtual
🔗 oligo-nucleotide.com
#OTDC2027 #RNA #DrugDelivery
September 29, 2026 at 3:52 AM
WuXi AppTec maps the manufacturing gauntlet for long-acting oligonucleotides: chemistry, purification, stability. Monthly-plus dosing demands new process engineering. TIDES platform outlines where the hard problems live.
WuXi AppTec outlines long-acting oligonucleotide manufacturing hurdles
WuXi AppTec's TIDES platform sets out the chemistry, purification and stability challenges that arise when engineering oligonucleotides for monthly or longer dosing
biotech.disruptsmedia.com
September 27, 2026 at 8:00 PM
N-of-1!

An investigational study of a novel individualised antisense oligonucleotide drug for CHCHD10-related #ALS shows early signs of efficacy in a 12-month N-of-1 study; Well tolerated, normalised plasma NfL levels & modest clinical improvements
www.cell.com/med/abstract...
September 27, 2026 at 9:32 AM
2'3'-cGAMP triggers membrane shearing in bacteria, revealing how cyclic-oligonucleotide signaling boosts antiviral defenses via 3TM effectors. Key insights into immunity mechanisms unveiled! PMID:41999741, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00344-2 #Medsky #Pharmsky 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00344-2
No description available
www.cell.com
September 27, 2026 at 2:00 AM
A photolabile oligonucleotide system has been developed, enabling spatially resolved single-cell transcriptomics and epigenomics studies. This system sheds light on how the epigenome influences gene expression. Published in Nature Biotechnology on 25 Sept 2026.
September 26, 2026 at 10:02 PM
A new photolabile oligonucleotide system unveiled in Nature Biotechnology allows spatially resolved single-cell measurements. Researchers can now study how the epigenome influences gene expression. This breakthrough enhances our understanding of cellular processes.
September 26, 2026 at 8:04 PM
Revolutionary photolabile oligonucleotide system enables spatially resolved single-cell transcriptomics and epigenomics, revealing gene expression regulation. Published in Nature Biotechnology, this breakthrough opens new avenues for understanding cellular processes! 🧬🔬
September 26, 2026 at 1:04 PM